Devin Smith
Devin Smith is the CEO of Arbor Biotechnologies, a company specializing in the development of advanced gene editing technologies and therapies. Under his leadership, Arbor is at the forefront of leveraging genomic science to create innovative treatments for rare and genetic diseases. Smith is recognized for his commitment to transforming genomic insights into practical therapies, and he actively collaborates with organizations like the Department of Health - Abu Dhabi to enhance clinical research and development in gene editing.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Arab Emirates:
Devin Smith is the CEO of Arbor Biotechnologies and expresses optimism about the collaboration with the Department of Health - Abu Dhabi to advance gene editing sciences.
8